AuntMinnie.com staff writers

AI
NQF seeks comments on 'high stakes' healthcare quality measurement
Initiative may eventually inform broader applications beyond accountability programs.
September 26, 2025
Artificial Intelligence Ai Binary Code Social (1)
Radiation Oncology/Therapy
Accuray introduces Stellar adaptive radiotherapy system
Stellar expands the range of available radiation delivery options offered by Accuray.
September 26, 2025
Accuray Astro 2019 Social
CT
Philips launches new radiation oncology offerings
Philips
The company is debuting Rembra RT and Areta RT CT platforms and helium free BlueSeal RT 1.5T 70cm MR system.
September 26, 2025
Philips' Rembra RT CT platform
Associations
AdvaMed comments on security investigation for medtech imports
AdvaMed has commented on the U.S. Department of Commerce's investigation into national security implications for medtech imports.
September 25, 2025
Lab Diagnostic Analyzer Woman 400
Radiation Oncology/Therapy
GE HealthCare to debut updates to iRT at ASTRO 2025
GE HealthCare
GE HealthCare plans to debut updates to Intelligent Radiation Therapy (iRT) for radiation oncology workflows.
September 25, 2025
Ge Health Care Logo
Practice Management
Siemens Healthineers opens first U.S.-based 'experience center'
Siemens Healthineers
The 60,000-square-foot facility features the latest technologies in imaging, diagnostics, cancer care, and advanced therapies.
September 25, 2025
Download Press Release Image
AI
RamSoft signs distributorship agreement with Koios
RamSoft
RamSoft is entering a new distributorship agreement with Koios Medical.
September 25, 2025
Business Handshake 400
AI
ScreenPoint’s AI software to be tested in $16M trial
ScreenPoint Medical
The study is the first large-scale randomized trial of AI in breast cancer screening in the U.S.
September 24, 2025
Ai 1
Radiation Oncology/Therapy
ITM and TerThera ink supply deal for Tb-161
Like Lutetium-177, Tb-161 emits medium-range beta particles and has a similar half-life.
September 24, 2025
Isotopes1
Molecular Imaging
Lantheus and GEHC to launch PET agent for prostate imaging in Japan
GE HealthCare
GEHC will draw on its manufacturing network and R&D expertise following its acquisition in March 2025 of Nihon Medi-Physics.
September 24, 2025
Prostate Imaging
Page 1 of 200
Next Page
Top Stories
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
Molecular Imaging
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
Mri Head
MRI
New brain MRI imaging technique could help identify Alzheimer's
Research Highlighter Res
Radiology Education
Scholarly activity low among residency program directors
Dexa
Digital X-Ray
3D DEXA shows value in patients with prostate cancer
Digital Innovations Shaping the Future of Radiology
Sponsor Content
Digital Innovations Shaping the Future of Radiology
More in Home
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
September 26, 2025
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
New brain MRI imaging technique could help identify Alzheimer's
By Kate Madden Yee
Researchers used 7-tesla MRI to demonstrate how microvessel pulses in the brain's deep white matter increase with age.
September 26, 2025
Mri Head
Scholarly activity low among residency program directors
By Amerigo Allegretto
Study results point toward program directors focusing on administrative responsibilities rather than scholarly activity.
September 26, 2025
Research Highlighter Res
3D DEXA shows value in patients with prostate cancer
By Will Morton
3D DEXA may be a practical and valuable tool for detecting structural bone changes in prostate cancer patients.
September 25, 2025
Dexa
Smith-Bindman unpacks NEJM pediatric CT study
By Kate Madden Yee
In a video interview, the researcher acknowledged CT's importance to patient care but advocated for its appropriate use.
September 25, 2025
Rebecca Smith-Bindman, MD
Women who skip first mammogram more likely to die of breast cancer
By Amerigo Allegretto
Women who do not participate in their first breast cancer screening are 40% more likely to die later from the disease.
September 24, 2025
Mammography Breast Ipad Patient 400
Study finds AI not cost-effective for breast cancer screening
By Amerigo Allegretto
AI is not cost-effective for breast cancer screening, even with reductions in mortality, false-positive cases, and false-negative cases, according to new research.
September 24, 2025
Breast Tomosynthesis Digital 400 (1)
ACS: Cancer survival rates are lower in rural areas
By Kate Madden Yee
The research also reported lower cancer survival rates for Blacks compared to whites, underscoring "disparities in receipt of care."
September 24, 2025
Rural Res
Save power, curb carbon by switching off surplus CT scanners
By Kate Madden Yee
A new study's findings suggest a relatively easy way to "go green" in the radiology suite.
September 23, 2025
Planet Sustainability
Radiologists deem AI x-ray reports clinically acceptable
By Will Morton
There was no evidence of a difference in acceptability between AI- and radiologist-generated reports under a standard criterion.
September 23, 2025
Kara Cxr
ACR CEO talks imaging’s role in spending bill
By Amerigo Allegretto
Dana Smetherman, MD, CEO of the ACR, spoke with AuntMinnie.com about appropriations bills and how imaging may be affected.
September 23, 2025
American Flag Waving 400 (1)
Adding MBI to DBT finds more breast cancers
By Amerigo Allegretto
Adding molecular breast imaging (MBI) to DBT screening leads to more invasive cancers detected in women with dense breasts.
September 23, 2025
Images in a 62-year-old woman who presented for screening. (A) Image from DBT screening (the synthesized 2D mediolateral oblique view of the left breast is shown) at year on was interpreted as negative and showing heterogeneously dense breast. (B) Image from molecular breast imaging screening (mediolateral oblique view) at year one reveals a 0.9-cm non-mass focal area of uptake in the left breast (arrow). (C) Targeted ultrasound scan (transverse image) shows a suspicious mass in the 3-o’clock position of the left breast, 4 cm from the nipple. Ultrasound-guided core biopsy and lumpectomy revealed a 0.9-cm grade 2 invasive ductal carcinoma, an estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–negative lesion, with two sentinel nodes negative (N0).
Page 1 of 173
Next Page